​
​

Pharming Group Ownership 2024 | Who Owns Pharming Group Now?

OverviewRevenueFinancialsChartTranscripts

Institutional Ownership

0.03%

0

Institutional Holders

3.00

Pharming Group Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SILVERBERG BERNSTEIN CAPITAL MANAGEMENT LLC0.03%0.18%17,710--185,955Mar 31, 2024
MORGAN STANLEY0.00%-2,800--29,400Mar 31, 2024
UBS GROUP AG0.00%-5252100.00%546Mar 31, 2024

Pharming Group's largest institutional shareholder is SILVERBERG BERNSTEIN CAPITAL MANAGEMENT LLC, holding 0.03% of the company's total share outstanding, currently valued at $185.96K. The top 10 institutional shareholders own together 0.03% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SILVERBERG BERNSTEIN CAPITAL MANAGEMENT LLC0.03%0.18%17,710--185,955Mar 31, 2024
MORGAN STANLEY0.00%-2,800--29,400Mar 31, 2024
UBS GROUP AG0.00%-5252100.00%546Mar 31, 2024

The largest Pharming Group shareholder by % of total assets is SILVERBERG BERNSTEIN CAPITAL MANAGEMENT LLC. The company owns 17.71K shares of Pharming Group (PHAR), representing 0.18% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
UBS GROUP AG0.00%-5252100.00%546Mar 31, 2024
MORGAN STANLEY0.00%-2,800--29,400Mar 31, 2024
SILVERBERG BERNSTEIN CAPITAL MANAGEMENT LLC0.03%0.18%17,710--185,955Mar 31, 2024

As of Mar 31 2024, Pharming Group's largest institutional buyer is UBS GROUP AG. The company purchased 52.00 stocks of PHAR, valued at $546.00.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SILVERBERG BERNSTEIN CAPITAL MANAGEMENT LLC0.03%0.18%17,710--185,955Mar 31, 2024
MORGAN STANLEY0.00%-2,800--29,400Mar 31, 2024
UBS GROUP AG0.00%-5252100.00%546Mar 31, 2024

As of Mar 31 2024, Pharming Group's biggest institutional seller is SILVERBERG BERNSTEIN CAPITAL MANAGEMENT LLC. The company sold 0.00 shares of PHAR, valued at $185.96K.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
UBS GROUP AG0.00%-5252100.00%546Mar 31, 2024

Pharming Group's largest new institutional shareholder by number of shares is UBS GROUP AG, purchased 52.00 shares, valued at $546.00, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Pharming Group Mutual Fund Holders

Name% Total AssetsTotal SharesChange AmountChange %Date
TEMPLETON GLOBAL INVESTMENT TRUST0.10%297,837--Feb 29, 2024
FIDELITY CONCORD STREET TRUST0.00%2,093--Feb 29, 2024

Pharming Group's largest mutual fund holder by % of total assets is "TEMPLETON GLOBAL INVESTMENT TRUST", owning 297.84K shares, compromising 0.10% of its total assets.

Pharming Group Institutional Ownership Trends

Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 24350.00%
31 Dec, 232-
30 Sep, 232-
30 Jun, 232-33.33%
31 Mar, 233-
31 Dec, 223-
30 Sep, 223-
30 Jun, 223-25.00%
31 Mar, 22433.33%
31 Dec, 213-25.00%
30 Sep, 214-42.86%
30 Jun, 217133.33%
31 Mar, 21350.00%
31 Dec, 202-
30 Jun, 201-

As of 31 Mar 24, 3 institutions are holding Pharming Group's shares, representing an increase of 50.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 2420,5620.25%
31 Dec, 2320,51044.28%
30 Sep, 2314,215-43.05%
30 Jun, 2324,960-3.41%
31 Mar, 2325,841-12.43%
31 Dec, 2229,51018.12%
30 Sep, 2224,98422.04%
30 Jun, 2220,472-0.55%
31 Mar, 2220,58610.51%
31 Dec, 2118,628-29.45%
30 Sep, 2126,403-86.70%
30 Jun, 21198,4553.28%
31 Mar, 21192,149-89.87%
31 Dec, 201,896,857-
30 Jun, 2016,500-

Pharming Group (PHAR) has 20.56K shares outstanding as of 31 Mar 24, up 0.25% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 240.03%3291.48%
31 Dec, 230.03%6805.66%
30 Sep, 230.02%1403.35%
30 Jun, 230.04%2402.74%
31 Mar, 230.04%2214.55%
31 Dec, 220.04%3272.02%
30 Sep, 220.04%4122.97%
30 Jun, 220.03%3348.48%
31 Mar, 220.03%3534.48%
31 Dec, 210.03%1709.71%
30 Sep, 210.04%42.96%
30 Jun, 210.31%344.50%
31 Mar, 210.30%3.41%
31 Dec, 202.96%-
30 Jun, 200.03%-

As of 31 Mar 24, Pharming Group is held by 0.03% institutional shareholders, representing a 3291.48% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 241-50.00%
31 Dec, 232100.00%
30 Sep, 231-
30 Jun, 23--100.00%
31 Mar, 231-
31 Dec, 221-66.67%
30 Sep, 22350.00%
30 Jun, 222-
31 Mar, 222-
31 Dec, 212100.00%
30 Sep, 211-80.00%
30 Jun, 215150.00%
31 Mar, 212-
31 Dec, 202-
30 Jun, 201-

1 institutional shareholders have increased their position in PHAR stock as of 31 Mar 24 compared to 2 in the previous quarter (a -50.00% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 24--
31 Dec, 23--
30 Sep, 23--
30 Jun, 23--100.00%
31 Mar, 232-
31 Dec, 222-
30 Sep, 22--
30 Jun, 22--100.00%
31 Mar, 221-
31 Dec, 211-
30 Sep, 211-50.00%
30 Jun, 212100.00%
31 Mar, 211-
31 Dec, 20--
30 Jun, 20--

- institutional shareholders have reduced their position in PHAR stock as of 31 Mar 24 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 24350.00%20,5620.25%0.03%3291.48%1-50.00%--
31 Dec, 232-20,51044.28%0.03%6805.66%2100.00%--
30 Sep, 232-14,215-43.05%0.02%1403.35%1---
30 Jun, 232-33.33%24,960-3.41%0.04%2402.74%--100.00%--100.00%
31 Mar, 233-25,841-12.43%0.04%2214.55%1-2-
31 Dec, 223-29,51018.12%0.04%3272.02%1-66.67%2-
30 Sep, 223-24,98422.04%0.04%4122.97%350.00%--
30 Jun, 223-25.00%20,472-0.55%0.03%3348.48%2---100.00%
31 Mar, 22433.33%20,58610.51%0.03%3534.48%2-1-
31 Dec, 213-25.00%18,628-29.45%0.03%1709.71%2100.00%1-
30 Sep, 214-42.86%26,403-86.70%0.04%42.96%1-80.00%1-50.00%
30 Jun, 217133.33%198,4553.28%0.31%344.50%5150.00%2100.00%
31 Mar, 21350.00%192,149-89.87%0.30%3.41%2-1-
31 Dec, 202-1,896,857-2.96%-2---
30 Jun, 201-16,500-0.03%-1---

Pharming Group Insider Shareholders Trades

Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 12, 2004CAMDEN PARTNERS STRATEGIC FUND II A LPother See General Remarks and FN 1A-AwardBuy5,000$0.68$3.40K5,000

Pharming Group Insider Ownership Trends

All Insider Trades Trend

DateBuySellBuy/Sell Ratio

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio

Pharming Group Peer Ownership

TickerCompany
ANEBAnebulo Pharmaceuticals, Inc.
MLYSMineralys Therapeutics, Inc.
RZLTRezolute, Inc.
FENCFennec Pharmaceuticals Inc.
ELYMEliem Therapeutics, Inc.
ACRVAcrivon Therapeutics, Inc. Common Stock
LIANLianBio
PRTCPureTech Health plc
LRMRLarimar Therapeutics, Inc.
JANXJanux Therapeutics, Inc.
MOLNMolecular Partners AG
GNTAGenenta Science S.p.A.
VRCAVerrica Pharmaceuticals Inc.
FIXXQ32 Bio Inc.
PRDSPardes Biosciences, Inc.
OPTOpthea Limited

PHAR Ownership FAQ

Pharming Group is owned by institutional shareholders (0.03%), insiders (0.00%), and public (99.97%). The largest institutional shareholder of Pharming Group is SILVERBERG BERNSTEIN CAPITAL MANAGEMENT LLC (0.03% of total shares) and the top mutual fund owner is TEMPLETON GLOBAL INVESTMENT TRUST (0.10% of total shares).

Pharming Group's major institutional shareholders are SILVERBERG BERNSTEIN CAPITAL MANAGEMENT LLC, MORGAN STANLEY, and UBS GROUP AG. The top five shareholders own together 0.03% of the company's share outstanding.

As of Mar 2024, there are 3 institutional shareholders of Pharming Group.

SILVERBERG BERNSTEIN CAPITAL MANAGEMENT LLC owns 17.71K shares of Pharming Group, representing 0.03% of the company's total shares outstanding, valued at $185.96K (as of Mar 2024).

As of Mar 2024, MORGAN STANLEY holds 2.8K shares of Pharming Group (PHAR), compromising 0.00% of the company, valued at $29.4K.

UBS GROUP AG is the third largest holder of Pharming Group. The company owns 52 of the company's shares outstanding (worth $546).